Advancing Health Equity in Belgium: Challenges, Choices & Change Across the Medicine Lifecycle
On this day, Pharma.be and Healixia are bringing together leading experts, policymakers, industry representatives and patient voices to explore how equity can be embedded at every stage of the medicine lifecycle.
The event, jointly organized by pharma.be and Healixia, opens with a keynote by Prof. Dr. Sara Willems (Ghent University), who will frame equity as a cornerstone of a future-proof healthcare system, followed by an interactive Q&A. The program then moves into a series of focused perspectives along the medicine lifecycle: from how patients and citizens are informed (FAMHP), to gender gaps and women’s health, equity in clinical trials through the IHI-READI project, an industry view on end-to-end health equity from Gilead Sciences, and a lived patient perspective on equity in cancer care.
After a networking break, all speakers return to the stage for a moderated debate, connecting the insights from each session and engaging the audience in a forward-looking discussion on practical choices and collective responsibility. The afternoon concludes with closing remarks, followed by a networking drink to continue the conversation in an informal setting.
Click here to consult the full schedule.
CLICK HERE TO SECURE YOUR SPOT FOR THIS EVENT. You will be transferred to the pharma.be registration page. Participation is free of charge.
___________________________________________________________________________________________
Please note that the number of available seats is limited, we work on the basis of first come, first served. So please register as soon as possible to be sure you can attend.
Due to the large interest and the limited available seats, the number of representatives per company is restricted to 3 persons.
Participation to this event is free of charge. In the event of cancellation after 21 May, €110 including VAT will be charged. Please contact events@pharma.be to avoid these charges.